173 related articles for article (PubMed ID: 32071953)
1. Effect of a pulse-based diet and aerobic exercise on bone measures and body composition in women with polycystic ovary syndrome: A randomized controlled trial.
McBreairty LE; Kazemi M; Chilibeck PD; Gordon JJ; Chizen DR; Zello GA
Bone Rep; 2020 Jun; 12():100248. PubMed ID: 32071953
[TBL] [Abstract][Full Text] [Related]
2. Women With Polycystic Ovary Syndrome Have Comparable Hip Bone Geometry to Age-Matched Control Women.
McBreairty LE; Zello GA; Gordon JJ; Serrao SB; Pierson RA; Chizen DR; Chilibeck PD
J Clin Densitom; 2018; 21(1):54-60. PubMed ID: 28034591
[TBL] [Abstract][Full Text] [Related]
3. Body composition and reproductive function exert unique influences on indices of bone health in exercising women.
Mallinson RJ; Williams NI; Hill BR; De Souza MJ
Bone; 2013 Sep; 56(1):91-100. PubMed ID: 23702387
[TBL] [Abstract][Full Text] [Related]
4. The role of a pulse-based diet on infertility measures and metabolic syndrome risk: protocol of a randomized clinical trial in women with polycystic ovary syndrome.
McBreairty LE; Chilibeck PD; Chizen DR; Pierson RA; Tumback L; Sherar LB; Zello GA
BMC Nutr; 2017; 3():23. PubMed ID: 32153805
[TBL] [Abstract][Full Text] [Related]
5. Current and past menstrual status is an important determinant of femoral neck geometry in exercising women.
Mallinson RJ; Williams NI; Gibbs JC; Koehler K; Allaway HCM; Southmayd E; De Souza MJ
Bone; 2016 Jul; 88():101-112. PubMed ID: 27129885
[TBL] [Abstract][Full Text] [Related]
6. A Comparison of a Pulse-Based Diet and the Therapeutic Lifestyle Changes Diet in Combination with Exercise and Health Counselling on the Cardio-Metabolic Risk Profile in Women with Polycystic Ovary Syndrome: A Randomized Controlled Trial.
Kazemi M; McBreairty LE; Chizen DR; Pierson RA; Chilibeck PD; Zello GA
Nutrients; 2018 Sep; 10(10):. PubMed ID: 30274344
[TBL] [Abstract][Full Text] [Related]
7. A pulse-based diet and the Therapeutic Lifestyle Changes diet in combination with health counseling and exercise improve health-related quality of life in women with polycystic ovary syndrome: secondary analysis of a randomized controlled trial.
Kazemi M; McBreairty LE; Zello GA; Pierson RA; Gordon JJ; Serrao SB; Chilibeck PD; Chizen DR
J Psychosom Obstet Gynaecol; 2020 Jun; 41(2):144-153. PubMed ID: 31558086
[No Abstract] [Full Text] [Related]
8. A randomized controlled trial of a lifestyle intervention with longitudinal follow-up on ovarian dysmorphology in women with polycystic ovary syndrome.
Kazemi M; Pierson RA; McBreairty LE; Chilibeck PD; Zello GA; Chizen DR
Clin Endocrinol (Oxf); 2020 Jun; 92(6):525-535. PubMed ID: 32092167
[TBL] [Abstract][Full Text] [Related]
9. Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional study.
Pedersini R; Cosentini D; Rinaudo L; Zamparini M; Ulivieri FM; di Mauro P; Maffezzoni F; Monteverdi S; Vena W; Laini L; Amoroso V; Simoncini EL; Farina D; Mazziotti G; Berruti A
Bone Rep; 2023 Jun; 18():101654. PubMed ID: 36700242
[TBL] [Abstract][Full Text] [Related]
10. Determinants of Bone Mineral Density in Iranian Women with Polycystic Ovary Syndrome.
Karimi F; Mardani P
Int J Endocrinol Metab; 2023 Oct; 21(4):e137594. PubMed ID: 38666045
[TBL] [Abstract][Full Text] [Related]
11. Geometric indices of hip bone strength in obese, overweight, and normal-weight adolescent boys.
El Hage R
Osteoporos Int; 2012 May; 23(5):1593-600. PubMed ID: 21881968
[TBL] [Abstract][Full Text] [Related]
12. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
Ezeh U; Pall M; Mathur R; Azziz R
Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197
[TBL] [Abstract][Full Text] [Related]
13. Determinants of low bone mineral density in premenopausal polycystic ovary syndrome patients.
Karadağ C; Yoldemir T; Gogas Yavuz D
Gynecol Endocrinol; 2017 Mar; 33(3):234-237. PubMed ID: 27908213
[TBL] [Abstract][Full Text] [Related]
14. Obesity and Insulin Resistance, Not Polycystic Ovary Syndrome, Are Independent Predictors of Bone Mineral Density in Adolescents and Young Women.
Pereira-Eshraghi CF; Chiuzan C; Zhang Y; Tao RH; McCann M; Neugut YD; Printz A; Fennoy I; Cree-Green M; Oberfield SE; Sopher AB
Horm Res Paediatr; 2019; 92(6):365-371. PubMed ID: 32348991
[TBL] [Abstract][Full Text] [Related]
15. Influence of sarcopenia on bone health parameters in a group of eumenorrheic obese premenopausal women.
Hammoud E; Toumi H; Jacob C; Pinti A; Lespessailles E; El Hage R
J Bone Miner Metab; 2020 May; 38(3):385-391. PubMed ID: 31797065
[TBL] [Abstract][Full Text] [Related]
16. Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome.
Ganie MA; Chakraborty S; Sehgal A; Sreejith M; Kandasamy D; Jana M; Rashid A
Horm Metab Res; 2018 Oct; 50(10):754-760. PubMed ID: 30312986
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of muscle and bone composition and function in aging women with polycystic ovary syndrome.
Çelik Eroğlu B; Karaçoban L; Idılman IS; Korkusuz F; Yıldız BO
Maturitas; 2024 Jul; 185():107982. PubMed ID: 38579578
[TBL] [Abstract][Full Text] [Related]
18. Does the Severity of Obesity Influence Bone Mineral Density Values in Premenopausal Women?
Hammoud E; Toumi H; Jacob C; Pinti A; Lespessailles E; El Hage R
J Clin Densitom; 2021; 24(2):225-232. PubMed ID: 31109773
[TBL] [Abstract][Full Text] [Related]
19. Influence of the weight status on hip bone strength indices in a group of sedentary adolescent girls.
El Hage R; El Hage Z; Moussa E; Baddoura R; Theunynck D; Jacob C
J Med Liban; 2012; 60(1):30-6. PubMed ID: 22645899
[TBL] [Abstract][Full Text] [Related]
20. Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trial.
Glintborg D; Andersen M; Hagen C; Heickendorff L; Hermann AP
J Clin Endocrinol Metab; 2008 May; 93(5):1696-701. PubMed ID: 18285411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
